The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

EDITORIAL

Renal denervation for treatment of hypertension – will 2017 be the year of enlightenment?

EuroIntervention 2017;12:e2163-e2165 published online e-edition April 2017. DOI: 10.4244/EIJV12I18A355

1. Klinik für Innere Medizin III, Saarland University Hospital, Homburg/Saar, Germany; 2. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA; 3. Cardiovascular Division, Brigham and Women’s Hospital, H


Hypertension is accompanied by significant adverse cardiovascular outcomes, and intensive blood pressure lowering (<120 mmHg) in patients at risk improves outcomes1. However, although numerous highly effective pharmacological therapies are available to lower blood pressure, control rates remain unacceptably low. A substantial number of patients with hypertension are reluctant or incapable of adhering to lifestyle modification and/or poly pharmacotherapy regimens, especially as the former has a time-delimited impact on blood pressure and the latter requires a lifetime of adherence, which is challenging at best. Non-pharmacological control of blood pressure is appealing, and several interventional approaches have been developed and ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

The interventional cardiologist of the 3rd millennium

Latest news